Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Philippe Collet

Showing results (281-290 of 376) with videos related to

Pageof 38
Sort By:
Giornale Italiano Di Cardiologia (2006)|November 22, 2016
[2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)]Marco Roffi, Carlo Patrono, Jean-Philippe Collet, et al.
European Heart Journal|September 10, 2017
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS)Marco Valgimigli, Héctor Bueno, Robert A Byrne, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 19, 2017
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTSMarco Valgimigli, Héctor Bueno, Robert A Byrne, et al.
Circulation. Cardiovascular Interventions|March 16, 2019
Risk-Benefit Profile of Longer-Than-1-Year Dual-Antiplatelet Therapy Duration After Drug-Eluting Stent Implantation in Relation to Clinical PresentationTullio Palmerini, Antonio G Bruno, Martine Gilard, et al.
The American Journal of Cardiology|September 10, 2013
A direct comparison of intravenous enoxaparin with unfractionated heparin in primary percutaneous coronary intervention (from the ATOLL trial)Jean-Philippe Collet, Kurt Huber, Marc Cohen, et al.
Revista Espanola De Cardiologia (English Ed.)|December 18, 2015
2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment ElevationMarco Roffi, Carlo Patrono, Jean-Philippe Collet, et al.
European Heart Journal|August 31, 2015
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)Marco Roffi, Carlo Patrono, Jean-Philippe Collet, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 30, 2021
Bleeding in the Elderly: Risk Factors and Impact on Clinical Outcomes After an Acute Coronary Syndrome, a Sub-study of the Randomized ANTARCTIC TrialBenoit Lattuca, Guillaume Cayla, Johanne Silvain, et al.
American Heart Journal|December 3, 2014
Platelet function monitoring in elderly patients on prasugrel after stenting for an acute coronary syndrome: design of the randomized antarctic studyGuillaume Cayla, Thomas Cuisset, Johanne Silvain, et al.
Thrombosis and Haemostasis|December 7, 2017
Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)Gregory Y H Lip, Jean Philippe Collet, Raffaele de Caterina, et al.
Pageof 38

Showing results (281-290 of 376) with videos related to

Sort By:
Pageof 38
Giornale Italiano Di Cardiologia (2006)|November 22, 2016
[2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)]Marco Roffi, Carlo Patrono, Jean-Philippe Collet, et al.
European Heart Journal|September 10, 2017
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS)Marco Valgimigli, Héctor Bueno, Robert A Byrne, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 19, 2017
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTSMarco Valgimigli, Héctor Bueno, Robert A Byrne, et al.
Circulation. Cardiovascular Interventions|March 16, 2019
Risk-Benefit Profile of Longer-Than-1-Year Dual-Antiplatelet Therapy Duration After Drug-Eluting Stent Implantation in Relation to Clinical PresentationTullio Palmerini, Antonio G Bruno, Martine Gilard, et al.
The American Journal of Cardiology|September 10, 2013
A direct comparison of intravenous enoxaparin with unfractionated heparin in primary percutaneous coronary intervention (from the ATOLL trial)Jean-Philippe Collet, Kurt Huber, Marc Cohen, et al.
Revista Espanola De Cardiologia (English Ed.)|December 18, 2015
2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment ElevationMarco Roffi, Carlo Patrono, Jean-Philippe Collet, et al.
European Heart Journal|August 31, 2015
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)Marco Roffi, Carlo Patrono, Jean-Philippe Collet, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 30, 2021
Bleeding in the Elderly: Risk Factors and Impact on Clinical Outcomes After an Acute Coronary Syndrome, a Sub-study of the Randomized ANTARCTIC TrialBenoit Lattuca, Guillaume Cayla, Johanne Silvain, et al.
American Heart Journal|December 3, 2014
Platelet function monitoring in elderly patients on prasugrel after stenting for an acute coronary syndrome: design of the randomized antarctic studyGuillaume Cayla, Thomas Cuisset, Johanne Silvain, et al.
Thrombosis and Haemostasis|December 7, 2017
Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)Gregory Y H Lip, Jean Philippe Collet, Raffaele de Caterina, et al.
Pageof 38